Plasma tetranectin and ovarian neoplasms
- 1 November 1991
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 43 (2) , 103-107
- https://doi.org/10.1016/0090-8258(91)90053-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase.Journal of Clinical Investigation, 1990
- Evaluation of the Ovarian Cancer Antigen, CA-125, as a Tumor MarkerOncology, 1989
- Plasma tetranectin is reduced in cancer and related to metastasiaCancer, 1988
- Clinical evaluation of ovarian tumor antigen NB/70K: monoclonal antibody assays for distinguishing ovarian cancer from other gynecologic diseaseAmerican Journal of Obstetrics and Gynecology, 1988
- Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinomaCancer, 1988
- Primary structure of tetranectin, a plasminogen kringle 4 binding plasma protein: homology with asialoglycoprotein receptors and cartilage proteoglycan core proteinBiochemistry, 1987
- Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectinEuropean Journal of Biochemistry, 1986
- Plasminogen Activators, Tissue Degradation, and CancerPublished by Elsevier ,1985
- The Fibrinolytic SystemAnnals of Surgery, 1979
- Fibrin Degradation Products and Ovarian TumoursBMJ, 1971